Does P-Glycoprotein Play a Role in Gastrointestinal Absorption and Cellular Transport of Dietary Cholesterol?
暂无分享,去创建一个
[1] Jonathan D. Smith,et al. Reevaluation of the role of the multidrug-resistant P-glycoprotein in cellular cholesterol homeostasis Published, JLR Papers in Press, October 7, 2005. , 2006, Journal of Lipid Research.
[2] J. Tu,et al. Regional variation in self-reported heart disease prevalence in Canada. , 2005, The Canadian journal of cardiology.
[3] D. Gaudet,et al. Statin therapy in Canadian patients with hypercholesterolemia: the Canadian Lipid Study -- Observational (CALIPSO). , 2005, The Canadian journal of cardiology.
[4] M. Barančík,et al. P-glycoprotein--implications of metabolism of neoplastic cells and cancer therapy. , 2005, Current cancer drug targets.
[5] M. Hirata,et al. High baseline serum total and LDL cholesterol levels are associated with MDR1 haplotypes in Brazilian hypercholesterolemic individuals of European descent. , 2005, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[6] V. Ling,et al. Bile acid transport in sister of P-glycoprotein (ABCB11) knockout mice. , 2005, Biochemistry.
[7] B. Coll,et al. Turpentine-induced inflammation reduces the hepatic expression of the multiple drug resistance gene, the plasma cholesterol concentration and the development of atherosclerosis in apolipoprotein E deficient mice. , 2005, Biochimica et biophysica acta.
[8] P. Howles,et al. Molecular mechanisms of cholesterol absorption and transport in the intestine. , 2005, Seminars in cell & developmental biology.
[9] K. Qing,et al. Diet-induced changes in stearoyl-CoA desaturase 1 expression in obesity-prone and -resistant mice. , 2004, Obesity research.
[10] S. Turley. Cholesterol metabolism and therapeutic targets: Rationale for targeting multiple metabolic pathways , 2004, Clinical cardiology.
[11] P. Sinko,et al. Intestinal drug transporters: in vivo function and clinical importance. , 2004, Current drug metabolism.
[12] G. Chang. Multidrug resistance ABC transporters , 2003, FEBS letters.
[13] H. Glaeser,et al. P‐glycoprotein‐mediated intestinal and biliary digoxin transport in humans , 2003, Clinical pharmacology and therapeutics.
[14] Folkert Kuipers,et al. Mdr P‐glycoproteins are not essential for biliary excretion of the hydrophobic heme precursor protoporphyrin in a griseofulvin‐induced mouse model of erythropoietic protoporphyria , 2002, Hepatology.
[15] D. Piwnica-Worms,et al. Decreased hepatic accumulation and enhanced esterification of cholesterol in mice deficient in mdr1a and mdr1b P-glycoproteins. , 2001, Journal of lipid research.
[16] E. Wang,et al. Cholesterol interaction with the daunorubicin binding site of P-glycoprotein. , 2000, Biochemical and biophysical research communications.
[17] U. Brinkmann,et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[18] W. Stenson,et al. Overexpression of MDR1 in an intestinal cell line results in increased cholesterol uptake from micelles. , 2000, Biochemical and biophysical research communications.
[19] F. Field,et al. Transport of cholesterol from the endoplasmic reticulum to the plasma membrane is constitutive in CaCo-2 cells and differs from the transport of plasma membrane cholesterol to the endoplasmic reticulum. , 1998, Journal of lipid research.
[20] Balázs Sarkadi,et al. The role of ABC transporters in drug resistance, metabolism and toxicity. , 2004, Current drug delivery.